Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
Go back to Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial| PACIFIC BOOKER MINERALS, Inc. (NASDAQ: PBM) | Delayed: 5.02 -0.06 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.08 | 52 Week High | $4.56 | |||
| Open | $5.08 | 52 Week Low | $0.45 | |||
| Day High | $5.30 | P/E | N/A | |||
| Day Low | $4.89 | EPS | $0.00 | |||
| Volume | 51,187 | |||||



